Lv54
930 积分 2024-01-17 加入
Psoriasis: is the impairment to a patient’s life cumulative?
3小时前
已完结
Disease modification in inflammatory skin disorders: opportunities and challenges
3小时前
已完结
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
2天前
已完结
IL-4-induced decrease in both the number and CTLA-4 expression of Treg impairs suppression of Th2 type inflammation in severe atopic dermatitis
2天前
已完结
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
2天前
已完结
Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab
2天前
已完结
In search of the Holy Grail in atopic dermatitis: Will dupilumab become the first disease-modifying atopic dermatitis drug?
3天前
已完结
Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study
7天前
已完结
Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study
7天前
已完结
Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis
7天前
已完结
皖公网安备34019202002308
